Literature DB >> 28716989

High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).

Pierre-François Plouin1, Jean-Philippe Baguet2, Frédéric Thony2, Olivier Ormezzano2, Arshid Azarine2, François Silhol2, Catherine Oppenheim2, Béatrice Bouhanick2, Louis Boyer2, Alexandre Persu2, Frank Hammer2, Philippe Gosse2, Claire Mounier-Vehier2, Claire Le Hello2, Xavier Jeunemaitre2, Michel Azizi2, Laurence Amar2, Gilles Chatellier2, Elie Mousseaux2, Emmanuel Touzé2.   

Abstract

Fibromuscular dysplasia (FMD) commonly affects the renal and cervical arteries but has been described to affect other vascular beds as well. The prevalence of and clinical characteristics associated with multisite FMD (string-of-beds or focal stenoses affecting at least 2 vascular beds) are not known. In the prospective ARCADIA registry (Assessment of Renal and Cervical Artery Dysplasia), symptomatic patients with renal artery (RA) FMD underwent tomographic- or magnetic resonance-angiography from the aortic arch to the intracranial arteries and those with cervical FMD from the diaphragm to the pelvis. Of 469 patients (84.0% women), 225 (48.0%) had multisite FMD. In addition, 86 of 244 patients with single-site disease had dissections or aneurisms affecting other vascular beds, totaling 311 patients (66.3%) with lesions in >1 vascular bed. Among patients with a cerebrovascular presentation, the prevalence of RA lesions was higher in patients with than in those without hypertension (odds ratio, 3.4; 95% confidence interval, 1.99-6.15). Among patients with a renal presentation, the prevalence of cervical lesions was higher in patients with bilateral than in those with unilateral RA lesions (odds ratio, 1.9; 95% confidence interval, 0.99-3.57). In conclusion, FMD is a systemic arterial disease. At least 2 vascular beds were affected by dysplastic stenoses in 48.0% of cases and by dysplastic stenoses, aneurysms, and dissections in 66.1% of cases. RA imaging should be proposed to hypertensive patients with a cerebrovascular presentation. Cervical artery imaging should be considered in patients with a renal presentation and bilateral RA lesions. CLINICAL TRIAL REGISTRATION: URL: www.Clinicaltrials.gov. Unique identifier: NCT02884141.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  carotid arteries; cerebrovascular disorders; fibromuscular dysplasia; hypertension; renal artery

Mesh:

Year:  2017        PMID: 28716989     DOI: 10.1161/HYPERTENSIONAHA.117.09539

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Pathological correlates of brain arterial calcifications.

Authors:  Steven D Shapiro; James Goldman; Susan Morgello; Lawrence Honig; Mitchell S V Elkind; Randolph S Marshall; Jay P Mohr; Jose Gutierrez
Journal:  Cardiovasc Pathol       Date:  2018-10-12       Impact factor: 2.185

2.  A plasma proteogenomic signature for fibromuscular dysplasia.

Authors:  Jeffrey W Olin; Antonio F Di Narzo; Valentina d'Escamard; Daniella Kadian-Dodov; Haoxiang Cheng; Adrien Georges; Annette King; Allison Thomas; Temo Barwari; Katherine C Michelis; Rihab Bouchareb; Emir Bander; Anelechi Anyanwu; Paul Stelzer; Farzan Filsoufi; Sander Florman; Mete Civelek; Stephanie Debette; Xavier Jeunemaitre; Johan L M Björkegren; Manuel Mayr; Nabila Bouatia-Naji; Ke Hao; Jason C Kovacic
Journal:  Cardiovasc Res       Date:  2020-01-01       Impact factor: 10.787

3.  Association of Multifocal Fibromuscular Dysplasia in Elderly Patients With a More Benign Clinical Phenotype: Data From the US Registry for Fibromuscular Dysplasia.

Authors:  Imad Bagh; Jeffrey W Olin; James B Froehlich; Eva Kline-Rogers; Bruce Gray; Esther S H Kim; Aditya Sharma; Ido Weinberg; Bryan J Wells; Xiaokui Gu; Heather L Gornik
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

4.  Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Authors:  Eikan Mishima; Shu Umezawa; Takehiro Suzuki; Miki Fujimura; Michiaki Abe; Junichiro Hashimoto; Takaaki Abe; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

Review 5.  Idiopathic Non-atherosclerotic Carotid Artery Disease.

Authors:  Andrea Harriott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

6.  Aortic Dimensions Are Larger in Patients With Fibromuscular Dysplasia.

Authors:  Arielle M Schwartz; Esther Kim; Patrick Gleason; Xiaona Li; Yi-An Ko; Bryan J Wells
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

Review 7.  Renovascular Hypertension.

Authors:  Sandra M Herrmann; Stephen C Textor
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-19       Impact factor: 4.741

Review 8.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

9.  FMD and SCAD: Sex-Biased Arterial Diseases With Clinical and Genetic Pleiotropy.

Authors:  Esther S H Kim; Jacqueline Saw; Daniella Kadian-Dodov; Malissa Wood; Santhi K Ganesh
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

10.  Fibromuscular dysplasia presenting with a deep vein thrombosis.

Authors:  Danielle Lam; Shirley Jansen; Jonathan Tibballs; Andrew McLean-Tooke
Journal:  BMJ Case Rep       Date:  2020-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.